Akers Biosciences (AKER) Reports Q3 Loss of $0.45/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Wall St futures tick higher as oil retreats ahead of inflation data
- Oil falls on weaker demand outlook and higher US stocks
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Birkenstock surges on revenue beat, higher full-year outlook
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Akers Biosciences Announces Q3 2015 Earnings
November 13, 2015 6:59 AM ESTFlagship Rapid HIT Test Set to be in 250 US Hospitals by Year End
Conference Call Scheduled for 9:00 a.m. EST Today
THOROFARE, N.J., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM:AKR.L), (the "Company," "Akers" or "Akers Bio"), a medical device company focused on reducing the cost of healthcare through faster, easier diagnostics, reports its earnings for the third quarter and nine months ended September 30, 2015.
Financial Highlights:
Total Revenue for nine months ended September 30, 2015 was $1,325,887... MoreAkers Biosciences Announces Q3 2015 Earnings
November 13, 2015 6:59 AM ESTFlagship Rapid HIT Test Set to be in 250 US Hospitals by Year End
Conference Call Scheduled for 9:00 a.m. EST Today
THOROFARE, N.J., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM:AKR.L), (the "Company," "Akers" or "Akers Bio"), a medical device company focused on reducing the cost of healthcare through faster, easier diagnostics, reports its earnings for the third quarter and nine months ended September 30, 2015.
Financial Highlights:
Total Revenue for nine months ended September 30, 2015 was $1,325,887... More